Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy

Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary syndrome (47.1%), reagents that enhance the a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Oncol
Principais autores: Fujimura, Taku, Tanita, Kayo, Sato, Yota, Kambayashi, Yumi, Furudate, Sadanori, Tsukada, Akira, Hashimoto, Akira, Aiba, Setsuya
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836287/
https://ncbi.nlm.nih.gov/pubmed/29515406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486278
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados